ECHA and its committees continue to review a proposal for a universal PFAS restriction. This position paper responds to the ECHA progress update reported on 20 November 2024 and recommends restriction options other than a ban, that account for different PFAS properties and risk profiles. In light of the upcoming Chemicals Industry Package and the revision of the Regulation on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), the Commission must establish a more proportionate, predictable and enforceable restriction.
Proportionate approach to the REACH universal per- and polyfluoroalkyl substances restriction proposal
Related items
Making web scraping rules work for AI
The European Data Protection Board’s draft guidelines on web scraping for generative AI are an opportunity to provide greater legal certainty and support Europe’s AI competitiveness. However, some proposed requirements risk creating disproportionate burdens for AI developers.
A pragmatic, risk-based approach is needed to ensure the rules reflect the technical realities of AI development. This includes proportionate transparency obligations, recognition of the need for diverse training datasets and greater alignment with the AI Act and Digital Omnibus. Clear, harmonised rules are essential to protect personal data while enabling innovation.
Read our consultation response to learn more about the recommendations.
:focal())
Digital Economy Conference 2026: in review
AmCham EU’s 13th Annual Transatlantic Digital Economy Conference took place on Thursday, 5 November, under the theme Cutting through complexity. The event brought together policymakers, regulators and industry leaders to discuss how clear, workable frameworks and closer EU-US cooperation can bring more coherence to the digital landscape and support economic growth.
:focal())
A compass for better care
Beating cancer is one fight; protecting the heart through treatment is another. Heart-related complications are now the second leading cause of death among cancer survivors, and with diagnoses in Europe expected to rise 18% by 2040, the challenge will only grow. COMPASS, a €50.5 million initiative bringing together more than 60 partners, is building an AI-powered system that helps flag cardiotoxicity risk early and personalise care, so oncologists and cardiologists can act sooner and keep cancer treatment on track. GE HealthCare leads the industry side of the work, helping turn the research into everyday clinical practice across Europe. Read the full story on Invested in Europe.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.